A major trial in frontotemporal dementia patients has found that oxytocin can help improve symptoms of apathy. A new study led by Western researchers suggests that frequent treatment with intranasal o ...

UK is part of a new study looking at alternative way to help dementia patients. The University of Kentucky is part of the Libby study, named for a late-stage dementia patient who inspired ...

As research continues, those involved say this would be a game changer, especially for patients with very limited options.

A new study led by Western researchers found frequent treatment with intranasal oxytocin – a hormone in the brain associated ...

Discover the power of music therapy for dementia. Learn how music can reduce distress and improve well-being in institutional ...

New drug approvals and a federal dementia care pilot program among the year's significant developments, according to the ...

New research shows diabetes medication SGLT-2 inhibitors lower dementia risk by up to 35%, offering hope for millions ...

ATx has created groundbreaking drugs for dementia and Alzheimer’s. The Icelandic startup just raised €26mn to advance the ...

Early research suggests GLP-1 drugs could prevent or treat Alzheimer's Disease. Results from a big clinical trial could soon ...

Timely diagnosis of dementia is crucial, to make sure that both patients and their caregivers receive adequate treatment and ...

Researchers at the University of Kentucky's Sanders-Brown Center on Aging are at the forefront of advancing dementia research ...

LEXINGTON, Ky. (WDKY) — University of Kentucky researchers who are involved in a clinical trial on the use of medical cannabis for late-stage dementia patients say the results could be a game ...